Arca
Skip to content
Tools
Tools

Doxycycline Hyclate Tablets

Recall D-1026-2018, part of FDA recall event 80659. See Major Pharmaceuticals's company page.

MAJOR PHARMACEUTICALS started this Class II drug recall on Jul 30, 2018 (voluntary: firm initiated); FDA lists it as terminated, terminated Dec 2, 2019.

  • Classification: Class II
  • Started: Jul 30, 2018
  • Status: Terminated

Why It Was Recalled

Class II

Failed Dissolution Specifications

Record

Product
Doxycycline Hyclate Tablets, USP, 100 mg, Rx Only, 30 tablets, 3 x 10 unit dose Cartons, Mfd. by: West-Ward Pharmaceuticals Corp., Eatontown, NY 07724; Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA. NDC: 0904-0430-04
Quantity
3,161 Cartons
Lots and codes
Lot: 71545AA, exp 7/2019
Distribution
Nationwide USA
Recalling firm
MAJOR PHARMACEUTICALS, Livonia, MI, United States
How the firm notified
Letter
FDA classified
Aug 2, 2018

MAJOR PHARMACEUTICALS's Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA drug enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.